Adagio Medical Holdings, Inc Common Stock Total Liabilities
Adagio Medical Holdings, Inc Common Stock total liabilities. Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has total liabilities worth $34.30 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ADGM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Adagio Medical Holdings, Inc Common Stock (2020–2025)
Total liabilities of Adagio Medical Holdings, Inc Common Stock from 2020 to 2025. This chart illustrates how Adagio Medical Holdings, Inc Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Adagio Medical Holdings, Inc Common Stock Competitors by Total Liabilities
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eleco PLC
LSE:ELCO
|
UK | GBX28.36 Million |
|
Tristel
LSE:TSTL
|
UK | GBX11.88 Million |
|
Hall of Fame Resort Entertainment Co
NASDAQ:HOFV
|
USA | $325.72 Million |
|
UIL Ltd
LSE:UTL
|
UK | GBX66.12 Million |
|
Synthomer plc
LSE:SYNT
|
UK | GBX1.46 Billion |
|
paragon GmbH & Co. KGaA
F:PGN
|
Germany | €106.61 Million |
|
Kontrol Energy Corp
NEO:KNR
|
Canada | CA$5.51 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Adagio Medical Holdings, Inc Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ADGM total assets.
Liquidity & Leverage Metrics
Adagio Medical Holdings, Inc Common Stock Total Liabilities Ratios Explained
Adagio Medical Holdings, Inc Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -82.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adagio Medical Holdings, Inc Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adagio Medical Holdings, Inc Common Stock (2020–2025)
The table below shows the annual total liabilities of Adagio Medical Holdings, Inc Common Stock from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $30.85 Million | +8.11% |
| 2024-12-31 | $28.54 Million | -79.45% |
| 2023-12-31 | $138.85 Million | +32.77% |
| 2022-12-31 | $104.57 Million | +11.18% |
| 2021-12-31 | $94.06 Million | +167885.86% |
| 2020-12-31 | $55.99K | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more